LILETTA + LILETTA PATIENT COMMITMENT PROGRAM
Odyssea Pharma SPRL
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86913971 |
| Registration Number | 5346931 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Law Office Assigned | M90 |
| Employee Name | BELL, MARLENE D |
Timeline
| 2016-02-19 | Application Filed |
| 2016-03-31 | Date of First Use |
| 2016-12-20 | Published for Opposition |
| 2017-10-25 | Location: PUBLICATION AND ISSUE SECTION |
| 2017-11-28 | Status: Live/Registered |
| 2017-11-28 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Odyssea Pharma SPRL |
| Address | RUE DU TRAVAIL 15 GRÃCE-HOLLOGNE BE 4460 |
| Legal Entity Type | Company |
| Legal Entity State | BE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260314 | Ovals, three or more; Three or more ovals |
| 260316 | Ovals touching or intersecting |
| 260321 | Ovals that are completely or partially shaded |
Attorney of Record
Good, Services, and Codes
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2016-02-23 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-02-25 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2016-02-26 | 3 MDSM E:E-Mail |
| ASSIGNED TO EXAMINER | 2016-06-04 | 4 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | 2016-06-10 | 5 CPEA R:Renewal |
| EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | 2016-06-10 | 6 GEAP F:First Action |
| NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | 2016-06-10 | 7 GEAN O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2016-06-10 | 8 ALIE A:Allowance for Publication |
| COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | 2016-06-13 | 9 CEPE I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-11-09 | 10 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-11-16 | 11 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-11-30 | 12 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2016-12-20 | 13 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-12-20 | 14 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-02-14 | 15 NOAM E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2017-07-28 | 16 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2017-08-21 | 17 AITU A:Allowance for Publication |
| USE AMENDMENT FILED | 2017-07-28 | 18 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2017-08-23 | 19 SUPC I:Incoming Correspondence |
| SU - NON-FINAL ACTION - WRITTEN | 2017-09-07 | 20 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2017-09-07 | 21 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-09-07 | 22 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-09-29 | 23 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-10-04 | 24 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-10-04 | 25 TEME I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2017-10-25 | 26 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2017-10-26 | 27 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2017-11-28 | 28 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2022-11-28 | 29 REM1 E:E-Mail |
| CANCELLED SEC. 8 (6-YR) | 2024-06-07 | 30 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LILETTA + LILETTA PATIENT COMMITMENT PROGRAM 86917074 5346938 Live/Registered |
Odyssea Pharma SPRL 2016-02-23 |
 LILETTA + LILETTA PATIENT COMMITMENT PROGRAM 86913971 5346931 Live/Registered |
Odyssea Pharma SPRL 2016-02-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 